Volitionrx Stock Analysis
| VNRX Stock | USD 0.68 0.01 1.62% |
Volitionrx is undervalued with Real Value of 1.36 and Target Price of 3.42. The main objective of Volitionrx stock analysis is to determine its intrinsic value, which is an estimate of what Volitionrx is worth, separate from its market price. There are two main types of Volitionrx's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Volitionrx's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Volitionrx's stock to identify patterns and trends that may indicate its future price movements.
The Volitionrx stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Volitionrx is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Volitionrx Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Volitionrx's ongoing operational relationships across important fundamental and technical indicators.
Volitionrx |
Volitionrx Stock Analysis Notes
About 24.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.5. Volitionrx had not issued any dividends in recent years. VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company operates Nucleosomics a technology platform for blood test. Volitionrx operates under Diagnostics Research classification in the United States and is traded on AMEX Exchange. It employs 83 people. For more information please call Cameron Reynolds at 646 650 1351 or visit https://www.volition.com.Volitionrx Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Volitionrx's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Volitionrx or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Volitionrx generated a negative expected return over the last 90 days | |
| Volitionrx has some characteristics of a very speculative penny stock | |
| Volitionrx has high historical volatility and very poor performance | |
| Volitionrx has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 775.3 K. Net Loss for the year was (35.32 M) with profit before overhead, payroll, taxes, and interest of 306.39 K. | |
| Volitionrx currently holds about 16.42 M in cash with (18.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
| Volitionrx has a frail financial position based on the latest SEC disclosures | |
| Roughly 24.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: VolitionRx Limited to Post Q1 2024 Earnings of Per Share, Zacks Small Cap Forecasts - Defense World |
Volitionrx Upcoming and Recent Events
Earnings reports are used by Volitionrx to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Volitionrx previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Volitionrx Largest EPS Surprises
Earnings surprises can significantly impact Volitionrx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-03-22 | 2020-12-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2023-11-14 | 2023-09-30 | -0.13 | -0.11 | 0.02 | 15 | ||
2023-03-15 | 2022-12-31 | -0.15 | -0.13 | 0.02 | 13 |
Volitionrx Thematic Classifications
In addition to having Volitionrx stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Volitionrx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 56.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Volitionrx's market, we take the total number of its shares issued and multiply it by Volitionrx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Volitionrx Profitablity
Volitionrx's profitability indicators refer to fundamental financial ratios that showcase Volitionrx's ability to generate income relative to its revenue or operating costs. If, let's say, Volitionrx is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Volitionrx's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Volitionrx's profitability requires more research than a typical breakdown of Volitionrx's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.26) | (1.33) | |
| Return On Capital Employed | 9.26 | 9.72 | |
| Return On Assets | (1.26) | (1.33) | |
| Return On Equity | 4.53 | 4.75 |
Management Efficiency
Volitionrx has return on total asset (ROA) of (0.9727) % which means that it has lost $0.9727 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.3006) %, meaning that it created substantial loss on money invested by shareholders. Volitionrx's management efficiency ratios could be used to measure how well Volitionrx manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Volitionrx's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to rise to 4.75 in 2024, whereas Return On Tangible Assets are likely to drop (1.33) in 2024. At this time, Volitionrx's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 22.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 3.8 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.11) | (0.10) | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | (0.12) | (0.11) | |
| Enterprise Value Over EBITDA | (1.05) | (1.10) | |
| Price Book Value Ratio | (6.55) | (6.87) | |
| Enterprise Value Multiple | (1.05) | (1.10) | |
| Price Fair Value | (6.55) | (6.87) | |
| Enterprise Value | 36.2 M | 68.4 M |
The analysis of Volitionrx's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Volitionrx's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Volitionrx Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.346 |
Technical Drivers
As of the 16th of April 2024, Volitionrx has the Variance of 28.48, coefficient of variation of (3,030), and Risk Adjusted Performance of (0.01). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Volitionrx, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Volitionrx, which can be compared to its competition. Please validate Volitionrx information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Volitionrx is priced more or less accurately, providing market reflects its prevalent price of 0.6788 per share. As Volitionrx is a penny stock we also advise to double-check its jensen alpha numbers.Volitionrx Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Volitionrx middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Volitionrx. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Volitionrx Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Volitionrx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Volitionrx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Volitionrx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Edward Futcher over a week ago Acquisition by Edward Futcher of 8500 shares of Volitionrx subject to Rule 16b-3 | ||
Retter Andrew over three weeks ago Disposition of tradable shares by Retter Andrew of Volitionrx subject to Rule 16b-3 | ||
Jason Terrell over three months ago Volitionrx exotic insider transaction detected |
Volitionrx Predictive Daily Indicators
Volitionrx intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Volitionrx stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Volitionrx Forecast Models
Volitionrx's time-series forecasting models are one of many Volitionrx's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Volitionrx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Volitionrx Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Volitionrx prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Volitionrx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Volitionrx. By using and applying Volitionrx Stock analysis, traders can create a robust methodology for identifying Volitionrx entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (46.02) | (48.32) | |
| Operating Profit Margin | (46.42) | (48.74) | |
| Net Loss | (45.56) | (47.83) | |
| Gross Profit Margin | (0.82) | (0.86) |
Current Volitionrx Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Volitionrx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Volitionrx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 3.42 | Strong Buy | 4 | Odds |
Most Volitionrx analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Volitionrx stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Volitionrx, talking to its executives and customers, or listening to Volitionrx conference calls.
Volitionrx Stock Analysis Indicators
Volitionrx stock analysis indicators help investors evaluate how Volitionrx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Volitionrx shares will generate the highest return on investment. By understating and applying Volitionrx stock analysis, traders can identify Volitionrx position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 10.9 M | |
| Long Term Debt | 3.6 M | |
| Common Stock Shares Outstanding | 71.2 M | |
| Total Stockholder Equity | -7.8 M | |
| Property Plant And Equipment Net | 6.1 M | |
| Cash And Short Term Investments | 20.7 M | |
| Cash | 20.7 M | |
| Accounts Payable | 3.2 M | |
| Net Debt | -14.9 M | |
| 50 Day M A | 0.9274 | |
| Total Current Liabilities | 31.8 M | |
| Other Operating Expenses | 36.8 M | |
| Non Current Assets Total | 6.1 M | |
| Non Currrent Assets Other | -1.00 | |
| Stock Based Compensation | 2.3 M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Volitionrx. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Volitionrx Stock analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Volitionrx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Volitionrx. If investors know Volitionrx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Volitionrx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Revenue Per Share 0.011 | Quarterly Revenue Growth 1.038 | Return On Assets (0.97) | Return On Equity (7.30) |
The market value of Volitionrx is measured differently than its book value, which is the value of Volitionrx that is recorded on the company's balance sheet. Investors also form their own opinion of Volitionrx's value that differs from its market value or its book value, called intrinsic value, which is Volitionrx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Volitionrx's market value can be influenced by many factors that don't directly affect Volitionrx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Volitionrx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Volitionrx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Volitionrx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.